相关实验视频

Updated: Jul 19, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.1K

免疫检查点抑制剂基序列化疗对最初无法切除的周周胆管癌的完整反应后的转换手术:一个病例报告

Takahiro Tomino1, Keishi Sugimachi1, Tadatoshi Kakimoto2

  • 1Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, Fukuoka, Fukuoka, Japan.

Surgical case reports
|December 29, 2025
PubMed
概括

连续化疗,包括凝丁,思丁和S-1 (GCS),其次是凝丁,思丁和杜尔瓦卢马布 (GCD),使不可切割的周围胆管癌 (PHCC) 的转化手术成为可能,并实现了病理完整反应 (pCR). 这种方法可能会扩大高级PHCC的治疗选择.

关键词:
在GCD化疗中使用GCD化疗.在GCS化疗中使用GCS化疗.转换手术是转换手术.病态的完整反应.周围的胆性胆癌 (Perihilar Cholangiocarcinoma) 是一种癌症.

更多相关视频

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

650
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

663

相关概念视频

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...